Elisa-Marlen Dietrich, LL.M. (Turin)

柏林德国

Elisa-Marlen is a member of the Practice Area Technology, Media & Telecoms (TMT). She primarily advises IT and media companies on data protection, IT contract and e-commerce law as well as on other technology-related legal questions.

CV

Since 2024 Senior Associate, Taylor Wessing

2021 - 2024 Associate, Taylor Wessing

2018 – 2019 Associate, Luther Rechtsanwaltsgesellschaft, Berlin

职业发展

Since 2024 Senior Associate, Taylor Wessing

2021 - 2024 Associate, Taylor Wessing

2018 – 2019 Associate, Luther Rechtsanwaltsgesellschaft, Berlin

教育

2019 – 2020 LL.M. studies, University of Turin

2017 Second state examination, Berlin

2015 – 2017 Legal clerkship, Kammergericht Berlin

语言

最新新闻和观点

View Elisa-Marlen's insights

点击此处了解更多

技术、媒体与通信 (TMC)

The “Withdrawal Button”: A new compliance risk for (non-)EU businesses

2026年2月20日

作者 Nathalie Koch, LL.M. (UC Hastings) 以及 Elisa-Marlen Dietrich, LL.M. (Turin)

Interface - The EUs Digital Services Act

National enforcement of the Digital Services Act

Elisa-Marlen Eschborn looks at the Member State enforcement provisions of the DSA.

2022年9月19日

作者 Elisa-Marlen Dietrich, LL.M. (Turin)

22 / 23 观点

点击此处了解更多

技术、媒体与通信 (TMC)

The EU's digitization plans and their impact on companies

Digital Legal Academy Deep Dive

2022年9月8日

In-depth analysis

作者

点击此处了解更多

Elisa-Marlen Dietrich, LL.M. (Turin)

专长

执业领域和服务团队

行业

CV

职业发展

教育

语言

最新新闻和观点

The “Withdrawal Button”: A new compliance risk for (non-)EU businesses

Elisa-Marlen Dietrich, LL.M. (Turin)

专长

执业领域和服务团队

行业

CV

职业发展

教育

语言

最新新闻和观点

The “Withdrawal Button”: A new compliance risk for (non-)EU businesses

Related news & insights

The UPC’s first referral to the European Court of Justice: Cross-border preliminary injunctions against intermediaries and non-UPC defendants

Hungarian supreme court on legal standing to challenge generic marketing authorisations

Case law – VfGH on the eImpfpass and central vaccination register

The new Product Liability Directive: three life sciences priorities before the 2026 deadline

Update: AI-Enabled Medical Devices and IVDs Confirmed as “High-Risk”

Poland’s new AI systems act: a regulator and practical tools

Medical Cannabis Platforms Breach Advertising Ban

France renews its simplified anti-gift conventions – what life sciences companies operating in France need to know

Life Sciences Legal Lens Vol. 2

CJEU on distributor's verification obligations under MDR

相关人员

与我会面：